Toggle navigation
Menu
Home
News
Local
National
World
Politics
Sports
Entertainment
Business
Health
News Tip Hotline
Weather
Bend
Traffic
Live Traffic Cams
Central Oregon
Mountain Passes
Road Reports
Trip Check
Gas Prices
Closures and Delays
Stations
KQAK-FM 105.7
The Peak 104.1
The Ranch 95.7 FM
KBNW-AM/FM
KRCO-AM
Events
Upcoming
Concerts
Submit An Event
Submit A PSA
Interviews
Inside Central Oregon
Central Oregon Spotlight
Water Wise Tips
HBG Interviews
Ray’s Random Questions
Just Used Cars as Heard on KQAK & The Ranch
About MCO
Contact/About Us
Advertise
Careers
Media Kit
Radio Stations
Contest Rules
Recent Quotes
View Full List
My Watchlist
iShares iBonds Dec 2026 Term Treasury ETF
Edit Watchlist
Indicators
Industrial Estimate
Composite Estimate
500 Stocks Estimate
Gold
Crude Oil
Central Oregon Stock Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(OP:
AIMI
)
0.0711
UNCHANGED
Last Price
Updated: 1:14 PM EDT, Jun 11, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about AIMI
AIM ImmunoTech Announces Recent Presentation on the Potential of Private-Public Partnerships for the Development of Oncology Therapies
July 02, 2025
From
AIM ImmunoTech Inc.
Via
GlobeNewswire
AIM ImmunoTech Announces NYSE American Notice of Noncompliance With Minimum Stockholders’ Equity Requirements
June 20, 2025
From
AIM ImmunoTech Inc.
Via
GlobeNewswire
AIM ImmunoTech Resumes Trading on NYSE American
June 17, 2025
Company trading under the ticker “AIM” NYSE American effective at the start of trading today, Tuesday, June 17th
From
AIM ImmunoTech Inc.
Via
GlobeNewswire
AIM ImmunoTech Granted U.S. Patent Covering Methods of Manufacturing Therapeutic dsRNA, Including Ampligen®
June 12, 2025
From
AIM ImmunoTech Inc.
Via
GlobeNewswire
AIM ImmunoTech Announces NYSE American Removal of Trading Suspension
June 12, 2025
Company expected to resume trading on the NYSE American on Tuesday, June 17, 2025
From
AIM ImmunoTech Inc.
Via
GlobeNewswire
AIM ImmunoTech Announces 1-for-100 Reverse Stock Split
June 11, 2025
From
AIM ImmunoTech Inc.
Via
GlobeNewswire
AIM ImmunoTech Announces the Presentation of Ampligen Oncology Data at the Recent Annual Meeting of the American Association of Immunologists
May 08, 2025
From
AIM ImmunoTech Inc.
Via
GlobeNewswire
AIM ImmunoTech Announces Trading Under the Ticker AIMI on the Pink Open Market
April 07, 2025
From
AIM ImmunoTech Inc.
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
581446795
Mozilla/5.0 (Windows NT 10.0; Win64; x64) AppleWebKit/537.36 (KHTML, like Gecko) Chrome/60.0.3112.113 Safari/537.36
00fbf3724072e3a4c643b60a8db5a8756c4f8c05
1
